__timestamp | Amicus Therapeutics, Inc. | Grifols, S.A. |
---|---|---|
Wednesday, January 1, 2014 | 47624000 | 180753000 |
Thursday, January 1, 2015 | 76943000 | 224193000 |
Friday, January 1, 2016 | 104793000 | 197617000 |
Sunday, January 1, 2017 | 149310000 | 288320000 |
Monday, January 1, 2018 | 270902000 | 240661000 |
Tuesday, January 1, 2019 | 286378000 | 276018000 |
Wednesday, January 1, 2020 | 308443000 | 294216000 |
Friday, January 1, 2021 | 272049000 | 354881000 |
Saturday, January 1, 2022 | 276677000 | 361140000 |
Sunday, January 1, 2023 | 152381000 | 330551000 |
Infusing magic into the data realm
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Grifols, S.A. and Amicus Therapeutics, Inc. have demonstrated contrasting strategies in their R&D investments. From 2014 to 2023, Grifols consistently outspent Amicus, with an average annual R&D budget approximately 41% higher. Notably, Grifols peaked in 2022, investing 3.6 times more than its 2014 expenditure. Meanwhile, Amicus showed a more volatile pattern, with a significant surge in 2018, nearly quadrupling its 2014 budget. However, by 2023, Amicus's R&D spending had decreased by 45% from its 2020 peak. These trends highlight the dynamic nature of R&D investments in the biotech sector, reflecting each company's strategic priorities and market challenges.
Who Prioritizes Innovation? R&D Spending Compared for Zoetis Inc. and Grifols, S.A.
Takeda Pharmaceutical Company Limited or Grifols, S.A.: Who Invests More in Innovation?
R&D Insights: How Teva Pharmaceutical Industries Limited and Amicus Therapeutics, Inc. Allocate Funds
Research and Development Expenses Breakdown: Genmab A/S vs Amicus Therapeutics, Inc.
R&D Insights: How Bio-Techne Corporation and Grifols, S.A. Allocate Funds
Grifols, S.A. vs MannKind Corporation: Strategic Focus on R&D Spending
R&D Insights: How Grifols, S.A. and BioCryst Pharmaceuticals, Inc. Allocate Funds
Research and Development: Comparing Key Metrics for Ionis Pharmaceuticals, Inc. and Amicus Therapeutics, Inc.
Comparing Innovation Spending: Alpine Immune Sciences, Inc. and Amicus Therapeutics, Inc.
Viking Therapeutics, Inc. vs Amicus Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: Amicus Therapeutics, Inc. vs HUTCHMED (China) Limited
Analyzing R&D Budgets: Amicus Therapeutics, Inc. vs Mesoblast Limited